Bishop Hans Edgar is a director of Lyell Immunopharma Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sana Biotechnology, Inc.
8 Apr 24
4
AGILENT TECHNOLOGIES, INC.
19 Mar 24
4
Sana Biotechnology, Inc.
8 Jan 24
4
Sana Biotechnology, Inc.
6 Oct 23
4
Lyell Immunopharma, Inc.
8 Sep 23
4
Sana Biotechnology, Inc.
6 Jul 23
4
Lyell Immunopharma, Inc.
20 Jun 23
4
Sana Biotechnology, Inc.
9 Jun 23
4
Sana Biotechnology, Inc.
6 Apr 23
4
AGILENT TECHNOLOGIES, INC.
20 Mar 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Apr 24 | SANA Sana Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 2,774 | 0.00 | 5,779,640 |
15 Mar 24 | A Agilent | Common Stock | Grant | Acquire A | No | No | 147.48 | 750 | 110.61 k | 24,976.307 |
15 Mar 24 | A Agilent | Common Stock | Grant | Acquire A | No | No | 147.48 | 1,678 | 247.47 k | 24,226.307 |
5 Jan 24 | SANA Sana Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 4,901 | 0.00 | 5,776,866 |
5 Oct 23 | SANA Sana Biotechnology | Common Stock | Grant | Acquire A | No | No | 0 | 6,925 | 0.00 | 5,771,965 |
8 Sep 23 | LYEL Lyell Immunopharma | Option Common Stock | Grant | Acquire A | No | No | 3.19 | 55,000 | 175.45 k | 55,000 |